Pioglitazone pays dividends in type 2 diabetes mellitus

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1612, 2007-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pioglitazone pays dividends in type 2 diabetes mellitus

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Pioglitazone is Effective Therapy for Elderly Patients with Type 2 Diabetes Mellitus

By Rajagopalan R. Perez A. Ye Z. Khan M. Murray F.T.

Drugs & Aging, Vol. 21, Iss. 4, 2004-01 ,pp. : 259-271

Adis International

Access to resources Recommend Favorite

Pioglitazone slows progression of CIMT in type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Pioglitazone: a valuable component of combination therapy for type 2 diabetes mellitus

By Papanas Nikolaos Katsiki Niki Hatzitolios Apostolos I Maltezos Efstratios

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1457-1461

Informa Healthcare

Access to resources Recommend Favorite

Pioglitazone: A Review of its Use in Type 2 Diabetes Mellitus

By Waugh John Keating Gillian M. Plosker Greg L. Easthope Stephanie Robinson Dean M.

Drugs, Vol. 66, Iss. 1, 2006-01 ,pp. : 85-109

Adis International

Access to resources Recommend Favorite